US Patent Issued to Washington University on March 24 for "Debaryomyces species as an indicator of non-healing ulcers in Crohn's disease" (Missouri Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,696, issued on March 24, was assigned to Washington University (St. Louis).

"Debaryomyces species as an indicator of non-healing ulcers in Crohn's disease" was invented by Thaddeus Stappenbeck (St. Louis) and Umang Jain (St. Louis).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for treating, selecting a treatment, and monitoring a treatment for an inflammatory bowel disease in a patient in need are disclosed. Treatments include administering an antifungal compound. The method for selecting and monitoring a treatment includes detecting a biomarker indicative of an amount of the fungus Debaryomyces hansenii within the sample. The treatment is ...